David Rescott Analyst PerformanceAnalyst at Truist FinancialDavid Rescott is a stock analyst at Truist Financial in the medical sector, covering 10 publicly traded companies. Over the past year, David Rescott has issued 36 stock ratings, including buy and hold recommendations. While full access to David Rescott's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Rescott's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings51 Last 4 YearsBuy Recommendations65.85% 27 Buy RatingsCompanies Covered10 Unique Companies Ratings Distribution41RatingsDistribution of strong buy, buy, hold, and sell ratings by David Rescott.RatingPercentageCount Strong Buy0.0%0 ratings Buy65.9%27 ratings Hold34.1%14 ratings Sell0.0%0 ratingsOut of 41 total stock ratings issued by David Rescott at Truist Financial, the majority (65.9%) have been Buy recommendations, followed by 34.1% Hold.Best & Worst CallsBest Call000.0%LIVNMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%MDTAug 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE50.0% of companies on NYSE5 companiesNASDAQ50.0% of companies on NASDAQ5 companiesDavid Rescott, an analyst at Truist Financial, currently covers 10 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical10 companies100.0%David Rescott of Truist Financial specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED INSTRUMENTS6 companies60.0%MED PRODUCTS3 companies30.0%MED/DENTAL - SUPP1 company10.0% David Rescott's Ratings History at Truist Financial Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsHAEHaemonetics5/8/2026Set Price Target$53.74$67.00$0.0000.00% ROILIVNLivaNova5/7/2026Lower Price Target$66.26$76.00Outperform$0.0000.00% ROIMMSIMerit Medical Systems5/1/2026Set Price Target$64.54$83.00$0.0000.00% ROIEWEdwards Lifesciences4/24/2026Boost Price Target$79.69$87.00Neutral$0.0000.00% ROIBSXBoston Scientific4/23/2026Lower Price Target$64.95$78.00Outperform$0.0000.00% ROIISRGIntuitive Surgical4/22/2026Boost Price Target$487.27$610.00Outperform$0.0000.00% ROIPRCTPROCEPT BioRobotics3/6/2026Initiated Coverage$25.35$30.00Neutral$0.0000.00% ROIPRCTPROCEPT BioRobotics3/5/2026Upgrade$25.26Hold$0.0000.00% ROISIBNSiBone2/24/2026Reiterated Rating$15.62$24.00Buy$0.0000.00% ROIMDTMedtronic2/18/2026Lower Price Target$96.33$100.00Neutral$0.0000.00% ROIFURIOUS (Ad)Marc Chaikin wrote the software now found on $25,000 Bloomberg Terminals used by professional Wall Street traders. He had walked away from the industry - until his wife Sandy's retirement savings were decimated by the very insiders he had built his system for. That experience drove him to reimagine his institutional-grade stock analysis system for independent investors. The result is the Power Gauge - designed to give everyday investors the same informational edge as Wall Street professionals.Learn more and claim Marc's number-one stock pick for 2026HAEHaemonetics2/6/2026Set Price Target$61.31$81.00$0.0000.00% ROIBSXBoston Scientific2/5/2026Lower Price Target$75.50$101.00Outperform$0.0000.00% ROIPENPenumbra1/16/2026Reiterated Rating$350.53$374.00Neutral$0.0000.00% ROIPENPenumbra1/16/2026Downgrade$350.93$374.00Hold$0.0000.00% ROIEWEdwards Lifesciences1/12/2026Set Price Target$83.66$90.00$0.0000.00% ROISIBNSiBone12/18/2025Boost Price Target$19.63$23.00Buy$0.0000.00% ROIPENPenumbra12/16/2025Set Price Target$308.72$345.00$0.0000.00% ROIMMSIMerit Medical Systems12/16/2025Set Price Target$86.41$108.00$0.0000.00% ROIMDTMedtronic12/16/2025Set Price Target$98.68$103.00$0.0000.00% ROILIVNLivaNova12/16/2025Set Price Target$63.06$75.00$0.0000.00% ROIEWEdwards Lifesciences12/16/2025Set Price Target$83.41$87.00Neutral$0.0000.00% ROIHAEHaemonetics12/15/2025Boost Price Target$80.27$99.00Outperform$0.0000.00% ROIEWEdwards Lifesciences12/5/2025Boost Price Target$85.72$88.00Neutral$0.0000.00% ROIMDTMedtronic11/19/2025Boost Price Target$100.83$109.00Neutral$0.0000.00% ROILIVNLivaNova11/13/2025Boost Price Target$56.62$70.00Outperform$0.0000.00% ROILIVNLivaNova11/6/2025Boost Price Target$49.07$63.00Outperform$0.0000.00% ROIMMSIMerit Medical Systems10/31/2025Set Price Target$86.39$103.00$0.0000.00% ROIEWEdwards Lifesciences10/31/2025Set Price Target$82.44$83.00$0.0000.00% ROIBSXBoston Scientific10/1/2025Boost Price Target$97.55$128.00Outperform$0.0000.00% ROIMDTMedtronic8/20/2025Boost Price Target$89.92$96.00Neutral$0.0000.00% ROIPENPenumbra7/30/2025Boost Price Target$256.22$285.00Outperform$0.0000.00% ROIPENPenumbra7/30/2025Set Price Target$253.08$310.00Buy$0.0000.00% ROIEWEdwards Lifesciences7/25/2025Boost Price Target$75.68$79.00Neutral$0.0000.00% ROIBSXBoston Scientific7/24/2025Boost Price Target$107.51$123.00Outperform$0.0000.00% ROIHAEHaemonetics6/26/2025Initiated Coverage$73.52$87.00Outperform$0.0000.00% ROIMDTMedtronic5/22/2025Lower Price Target$81.62$92.00Neutral$0.0000.00% ROILIVNLivaNova5/8/2025Boost Price Target$43.51$61.00Outperform$00.0000.00% ROIMMSIMerit Medical Systems4/25/2025Lower Price Target$94.67$110.00Outperform$00.0000.00% ROIPENPenumbra4/24/2025Boost Price Target$278.18$325.00Outperform$000.0000.00% ROIEWEdwards Lifesciences4/24/2025Boost Price Target$70.33$75.00Neutral$00.0000.00% ROITomorrow morning's stock alert (Ad)Our research analysts are set to release their next stock idea tomorrow morning just before 12:00 PM Eastern. Don't miss your chance to be the first to see our next stock pick.Get The Early Bird's Stock of the Day (Free)BSXBoston Scientific4/24/2025Boost Price Target$99.01$120.00Outperform$00.0000.00% ROIPENPenumbra4/24/2025Boost Price Target$291.34$330.00Buy$000.0000.00% ROIISRGIntuitive Surgical4/23/2025Lower Price Target$478.74$575.00Outperform$000.0000.00% ROIPENPenumbra4/11/2025Lower Price Target$267.12$315.00Buy$000.0000.00% ROIISRGIntuitive Surgical3/18/2025Lower Price Target$488.80$600.00Outperform$000.0000.00% ROIPENPenumbra2/19/2025Boost Price Target$270.99$328.00Outperform$000.0000.00% ROIMDTMedtronic2/19/2025Boost Price Target$86.05$91.00Neutral$00.0000.00% ROIPENPenumbra2/19/2025Boost Price Target$307.06$325.00Buy$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James FinancialBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
